SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Flora Growth completes cannabis exports to Europe

    By
    Home / Flora Growth completes cannabis exports to Europe

    Flora Growth Corp has confirmed it has completed exports of Colombian grown high-CBD dried cannabis flower to Switzerland and the Czech Republic.

    In addition, the company has also completed commercial exports of CBD to the United States. 

    Flora Growth has also launched its commercial website where approved buyers can learn about Flora’s cultivation and grow practices. Customers will also be able to initiate orders for high-THC and high-CBD dry flower as well as derivative products.

    Read more: Flora Growth meets Colombian senator as recreational bill introduced

    Chairman and CEO of Flora Growth, Luis Merchan, commented: “As our global distribution network continues to evolve, adding these three industry-leading countries to our footprint is a major milestone for Flora. 

    “Our cultivation operation in Colombia, which provides high-quality, high-margin flower and derivatives, has experienced increasing demand. 

    “These exports are a testament to our team’s ability to execute in a very complex global regulatory environment and create new commercial revenue for our company.

    “We are proud to help increase access to safe, legal CBD and THC to consumers all over the globe. We look forward to working closely with our partners in Europe and North America to bring high-quality Colombian cannabis products and raw materials to market.”

    The company also recently announced that it had entered an agreement with one of Colombia’s main indigenous tribes to process and distribute cannabis products.

    The joint venture agreement is with Pharma Indigena Misak Manasr Sas, the largest indigenous tribe in Colombia. Under the agreement, the outdoor cultivator, manufacturer and distributor will provide Manasr regulatory advice, technical and business support related to product development and distribution, promotion of products to be marketed under the Flora brand portfolio, and cannabis derivatives to complete product production.

    [activecampaign form=31]

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.